Prescription Information Modernization Act of 2025
Sponsor TBD · House Energy and Commerce (Health subcommittee) · 119th Congress · Referred to House Energy and Commerce
A Tier 2 administrative-modernization bill — the 119th Congress descendant of the original MODERN Labeling Act (S.3519, 115th Congress; H.R.5668, 116th Congress, provisions enacted in Consolidated Appropriations Act 2021). Authorizes the FDA to require updates to outdated drug labels. Pedagogically clean for showing how the Engine renders moderate-complexity regulatory statute — operative terms, distributional implications across consumers and industries, and the discretionary-to-mandatory transformation pattern.
Plain-language summary
Plain-language summary is in progress. The Engine will translate the bill text to a Flesch–Kincaid grade-8 reading level, preserving legal meaning, and publish the readability score alongside the summary.
Amendment tracking
Amendment tracking is in progress. Every stage of this bill's evolution — introduction through conference — will be rendered with plain-language annotations of what changed, by whom, and with what effect.
Legal-effect analysis
Legal-effect analysis is in progress. Operative terms — may, shall, authorized, required, prohibited, not less than, not more than — will be flagged inside the bill text and linked to plain-language consequence statements. Not legal advice.
Distributional impact
Distributional impact analysis is in progress. Projections will include income, geography, and demographic dimensions where public data supports projection, each with explicit confidence ranges and Lucas Critique caveats.
Tier classification & pathway
Show the prompt & methodology- Primary tier
- Tier 2
- All tiers
- Tier 2
- Pathway
- federal statute
- Blueprint reforms advanced
- administrative modernization (FDA labeling)
- Manuscript citations
- Ch. VI — The Mechanism — 'The Sequence' subsection (l. 432-435)
- Blueprint sections
- §F.2 Implementation Sequencing
- Editorial review
- MW · 2026-04-26
- Notes
- Tier 2 — Delphi panel's recommended starter bill for moderate-complexity regulatory analysis. Direct successor to MODERN Labeling Act framing. Senate companion: S.2027.
Source: https://www.congress.gov/bill/119th-congress/house-bill/4132/text — retrieved (pending toolchain run); content hash (pending).
Every bill analysis is versioned in the public repository. If you identify a factual error, a better source, or a refined analytical approach, file an issue. If you want to propose an alternative analysis, fork it.